Human POSH-like protein 1
OwnerMark Shannoninventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMark Shannoninventor
Estimating the term…
The invention provides isolated nucleic acids that encode human POSHL1, and fragments thereof, vectors for propagating and expressing human POSHL1 nucleic acids, host cells comprising the nucleic acids and vectors of the present invention, proteins, protein fragments, and protein fusions of the novel human POSHL1 isoforms, and antibodies thereto. The invention further provides transgenic cells and non-human organisms comprising human POSHL1 nucleic acids, and transgenic cells and non-human organisms with targeted disruption of the endogenous orthologue of the human POSHL1 gene. The invention further provides pharmaceutical formulations of the nucleic acids, proteins, and antibodies of the present invention, and diagnostic, investigational, and therapeutic methods based on the human POSHL1 nucleic acids, proteins, and antibodies of the present invention.
An isolated nucleic acid that encodes a POSH-like onco-protein that interacts with both small GTPases and the downstream effectors in the signal transduction pathway, comprising:
An isolated polypeptide, comprising:
A method of identifying agents that modulate the expression of human POSHL1, the method comprising:
A method of identifying agonists and antagonists of human POSHL1, the method comprising:
A method of diagnosing a disease caused by mutation in human POSHL1, comprising:
A method of diagnosing or monitoring a disease caused by altered expression of human POSHL1, comprising:
Dependencies are inferred from the claim text.